Staley Capital Advisers Increased By $649,865 Its Johnson&Johnson (JNJ) Position; Mitek Systems (MITK)’s Sentiment Is 1.19

July 25, 2017 - By Dolores Ford

Staley Capital Advisers Inc increased Johnson&Johnson (JNJ) stake by 2.99% reported in 2016Q4 SEC filing. Staley Capital Advisers Inc acquired 5,651 shares as Johnson&Johnson (JNJ)’s stock rose 6.85%. The Staley Capital Advisers Inc holds 194,905 shares with $22.46 million value, up from 189,254 last quarter. Johnson&Johnson now has $355.00B valuation. The stock decreased 1.70% or $2.3 during the last trading session, reaching $133.01. About shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since July 25, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Mitek Systems, Inc. develops, markets and sells mobile capture and identity verification software solutions for enterprise customers. The company has market cap of $343.61 million. The Company’s technology allows users to remotely deposit checks, open accounts, get insurance quotes, pay bills, as well as verify their identity by taking pictures of various documents with their camera-equipped smartphones and tablets instead of using the device keyboard. It has a 155.07 P/E ratio. The Company’s technology uses algorithms to correct image distortion, extract relevant data, route images to their desired location and process transactions.

Since February 1, 2017, it had 0 insider purchases, and 5 selling transactions for $14.98 million activity. On Tuesday, February 28 Kapusta Ronald A sold $1.78 million worth of Johnson & Johnson (NYSE:JNJ) or 14,543 shares. Ullmann Michael H sold 21,735 shares worth $2.45 million. Shares for $6.18M were sold by Duato Joaquin on Friday, March 3. 22,000 shares were sold by Stoffels Paulus, worth $2.58M on Wednesday, February 15. Pruden Gary J sold 16,299 shares worth $1.99 million.

Investors sentiment increased to 0.94 in Q4 2016. Its up 0.12, from 0.82 in 2016Q3. It is positive, as 63 investors sold JNJ shares while 834 reduced holdings. 114 funds opened positions while 731 raised stakes. 1.72 billion shares or 0.88% more from 1.71 billion shares in 2016Q3 were reported. Capstone Advisors reported 12,543 shares or 0.66% of all its holdings. 3,708 are owned by Alpha Windward Ltd. Calamos Wealth Limited Liability holds 61,971 shares or 1.15% of its portfolio. Fiduciary Of The Southwest Tx holds 0.56% or 14,803 shares in its portfolio. Hoertkorn Richard Charles stated it has 1.08% of its portfolio in Johnson & Johnson (NYSE:JNJ). Martin Inc Tn owns 2.19% invested in Johnson & Johnson (NYSE:JNJ) for 58,597 shares. 61,688 are owned by Cetera Advsr Ltd Company. Coastline Communications reported 51,135 shares. Finemark National Bank & Trust And Tru invested in 0.82% or 88,433 shares. Sandler Cap invested 0.02% in Johnson & Johnson (NYSE:JNJ). Mawer Ltd reported 1.72% in Johnson & Johnson (NYSE:JNJ). Nichols Asset Ltd Limited Liability Company reported 1.9% in Johnson & Johnson (NYSE:JNJ). Roffman Miller Assoc Pa invested in 3.31% or 190,263 shares. Navellier & Assoc owns 14,200 shares for 0.27% of their portfolio. The Minnesota-based Somerset Grp Incorporated Ltd Liability Co has invested 0.29% in Johnson & Johnson (NYSE:JNJ).

Among 22 analysts covering Johnson & Johnson (NYSE:JNJ), 10 have Buy rating, 4 Sell and 8 Hold. Therefore 45% are positive. Johnson & Johnson had 58 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Goldman Sachs on Monday, March 14. Piper Jaffray maintained Johnson & Johnson (NYSE:JNJ) rating on Tuesday, July 18. Piper Jaffray has “Hold” rating and $12000 target. Wells Fargo downgraded the shares of JNJ in report on Thursday, January 26 to “Market Perform” rating. The rating was initiated by Societe Generale with “Hold” on Wednesday, April 6. RBC Capital Markets maintained it with “Buy” rating and $13800 target in Monday, July 10 report. The rating was maintained by Cowen & Co on Tuesday, June 13 with “Buy”. The stock of Johnson & Johnson (NYSE:JNJ) earned “Outperform” rating by RBC Capital Markets on Wednesday, July 20. The rating was maintained by Argus Research on Wednesday, April 20 with “Buy”. Vetr downgraded Johnson & Johnson (NYSE:JNJ) rating on Monday, August 31. Vetr has “Strong-Buy” rating and $106.73 target. As per Friday, July 21, the company rating was downgraded by Alembic.

Since January 1, 0001, it had 0 insider purchases, and 3 sales for $269,458 activity.

The stock decreased 3.81% or $0.4 during the last trading session, reaching $10.1. About shares traded. Mitek Systems, Inc. (MITK) has declined 2.93% since July 25, 2016 and is downtrending. It has underperformed by 19.63% the S&P500.